Olanzapine-Based Triple Regimens Versus Neurokinin-1 Receptor Antagonist-Based Triple Regimens in Preventing Chemotherapy-Induced Nausea and Vomiting Associated with Highly Emetogenic Chemotherapy: A Network Meta-Analysis.
| Author | |
|---|---|
| Abstract | :
The current antiemetic prophylaxis for patients treated with highly emetogenic chemotherapy (HEC) included the olanzapine-based triplet and neurokinin-1 receptor antagonists (NK-1RAs)-based triplet. However, which one shows better antiemetic effect remained unclear. |
| Year of Publication | :
2018
|
| Journal | :
The oncologist
|
| Date Published | :
2018
|
| ISSN Number | :
1083-7159
|
| URL | :
http://theoncologist.alphamedpress.org/cgi/pmidlookup?view=long&pmid=29330211
|
| DOI | :
10.1634/theoncologist.2017-0378
|
| Short Title | :
Oncologist
|
| Download citation |